MetaCap

Cryo-Cell International (CCEL) vs Viemed Healthcare (VMD)

Head-to-head comparison of performance, valuation, growth, profitability and dividends. Prices delayed 15 minutes; data as of Nov 22, 2026.

Summary

Viemed Healthcare (VMD) has outperformed Cryo-Cell International (CCEL) over the past year, gaining 27.9% versus a gain of 1.5%. Over five years, VMD leads with a +62.9% price change compared with -66.3% for CCEL. Viemed Healthcare is the larger company by market cap ($322.8 million vs $33.5 million), about 9.6 times the size.

On valuation, Viemed Healthcare trades at a lower forward P/E (21.3x vs 207.5x for Cryo-Cell International). Viemed Healthcare converts more of its revenue into profit, with a net margin of 5.5% versus -7.7%.

Summary generated from market data by MetaCap's automated system. Methodology

Relative performance

CCEL+1.47%VMD+27.93%
+91%+28%-35%
Nov 21, 20251 yearNov 20, 2026
CCEL-66.12%VMD+56.33%
+136%+25%-86%
Nov 15, 20215 yearsNov 16, 2026

Percent change in share price from the first common trading day shown; excludes dividends.

Head-to-head

CCEL versus VMD key metrics
MetricCCELVMD
Share price$4.15$8.52
Market cap$33.46M$322.85M
1-day change0.00%-1.05%
YTD return+20.64%+14.67%
1-year return+1.47%+27.93%
5-year return-66.34%+62.91%
P/E ratio (TTM)—22.42
Forward P/E207.5021.30
EPS (TTM)$-0.24$0.38
Dividend yield0.00%0.00%
Annual dividend$0.00$0.00
Revenue (latest FY)$31.57M$270.28M
Revenue growth (YoY)-1.31%+20.52%
Net income (latest FY)$-2.43M$14.93M
Gross margin76.63%57.52%
Operating margin1.53%8.49%
Net margin-7.70%5.53%
52-week high$5.45$12.61
52-week low$2.72$6.60
Distance from 52-week high-23.85%-32.43%
Analyst consensus—buy
Avg. price target upside—+40.85%
Average volume13.02K247.43K
Shares outstanding8.06M37.89M
Employees721,490
SectorHealth CareHealth Care
IndustryMisc Health and Biotechnology ServicesMisc Health and Biotechnology Services

Highlighted cells mark the higher value for growth, returns, margins and yield, and the lower value for P/E ratios. Highlighting is a mechanical comparison, not a recommendation.

Key differences

  • Viemed Healthcare is about 9.6 times larger than Cryo-Cell International by market value ($322.85M vs $33.46M).
  • VMD has outperformed CCEL by 26.5 percentage points over the past year.
  • Viemed Healthcare is more profitable, keeping 5.5 cents of every revenue dollar as net income versus -7.7 cents for Cryo-Cell International.
  • Viemed Healthcare grew revenue faster in its latest fiscal year (+20.52% vs -1.31%).

About Cryo-Cell International

CCEL stock →

Cryo-Cell International, Inc. engages in cord blood and cord tissue cryopreservation services in the United States.

Health Care · Misc Health and Biotechnology Services · 72 employees

About Viemed Healthcare

VMD stock →

Viemed Healthcare, Inc., through its subsidiaries, provides home medical equipment (HME) and post-acute respiratory healthcare services in the United States. The company provides respiratory disease management solutions, including treatment of chronic obstructive pulmonary disease (COPD), which include non-invasive ventilation, percussion vests, and other therapies; and invasive and non-invasive ventilation and related equipment and supplies to patients suffering from COPD.

Health Care · Misc Health and Biotechnology Services · 1,490 employees

CCEL vs VMD FAQ

Which is bigger, Cryo-Cell International or Viemed Healthcare?

Viemed Healthcare (VMD) is larger, with a market capitalization of $322.85M compared with $33.46M for Cryo-Cell International (CCEL).

Which stock has performed better over the past year, CCEL or VMD?

VMD returned +27.93% over the past 12 months, compared with +1.47% for CCEL (price return, excluding dividends). Past performance does not predict future results.

Are Cryo-Cell International and Viemed Healthcare in the same industry?

Yes. Both are classified in the Misc Health and Biotechnology Services industry within the Health Care sector.

More comparisons